PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.

Summary: Scientists have discovered a surprising link between a gene associated with Parkinson’s disease and colon cancer. The gene, called PARK2, normally acts as a "tumor suppressor," meaning it helps put the brakes on uncontrolled cell growth. In a study of 100 colorectal cancer patients, researchers found that this gene was missing or damaged in 33% of cases.

When PARK2 is deleted—especially in combination with another common cancer mutation known as APC—it creates a "perfect storm" for cancer development. Experiments showed that mice missing just half of their PARK2 function developed intestinal polyps much faster than normal. This suggests that keeping PARK2 healthy is vital for preventing tumor growth in the gut.